Announcements

Polish Jutro Medical raises €12 million Series A led by KAYA VC and RIO ASI, with Inovo VC, to replace telemedicine with medical AI agents

by
Tom Cironis
March 19, 2025
Jutro Medical – the AI-first primary care provider integrating online and offline care – has raised €12 million in Series A led by KAYA VC and RIO ASI, with participation from existing investor Inovo VC. The funding includes a debt component provided by mBank.

Founded in 2020 by Adam Janczewski, with a goal of delivering exceptional medical care with technology that actually delivers value, Jutro Medical is a primary care provider for 70,000 patients. After 400,000 visits, the average visit rating on a 1–5 scale is 4.93, the NPS stands at 86, and the PMF score at 77%.

Today, Jutro Medical is an AI-first primary care clinic with its own medical AI agents, which have the potential to handle over 68% of teleconsultations. Patients start their appointments by chatting with an AI agent that collects necessary information and completes post-visit documentation, enabling doctors to concentrate on patient treatment. For straightforward medical cases, the AI agent significantly reduces appointment time with a median duration of 2 minutes and 37 seconds. 

Medical AI agents have been built on top of Jutro Medical’s proprietary electronic health record system, developed by the company from its inception to securely store patient data. Initially, these processes were performed by human agents during intake interviews before doctor consultations, ensuring the workflow was tested and validated through human interactions before being transitioned to AI. 

“When you break down complex healthcare delivery into hundreds of tasks done daily by the doctors and medical staff, you discover that only a tiny part of these tasks have anything to do with medicine and health. We’ve been dissecting these processes and turning them into skills that we can teach AI agents, so they can handle them end-to-end, shifting all operational tasks and red tape from human to AI. We are building medical AI agents who can take over all these tasks from doctors, allowing them to finally practice medicine”, says Adam Janczewski, CEO & Founder of Jutro Medical. 

To ensure safety, medical AI agents are supervised by doctors, who remain solely responsible for medical decisions and analyzing information gathered by AI. All patient data remains private and secure, as the LLM models powering the AI agents are developed and hosted internally by Jutro Medical.

Medical AI agents are an optional feature for the patients who opt in to the AI tools. If they choose not to, they can still have their doctor appointments in a more traditional way, either online or offline.

The funding will also be used to expand Jutro Medical’s physical footprint across Europe. The company is soon opening its first clinic in the Netherlands and will continue expanding in Poland. Jutro Medical aims to take care of 350,000 European lives within the next 24 months.

To achieve these goals, Jutro Medical has teamed up with experienced healthcare executives responsible for overseeing 227 clinics and contributing to €450 million in primary care revenue over the past decade. They include Bartosz Skawiński (CFO) and Konrad Michalski (Medical Director), who previously helped build PZU Zdrowie into Poland’s third-largest healthcare provider, and Marek Maleszyk (COO), who previously grew a primary care network from just one facility to 85 clinics with 2,000 employees, also as a COO.

“AI will benefit incumbents, and Adam has positioned Jutro Medical to capture maximum value as the technology matures. He has quietly tested what’s possible using LLMs, with 30 people acting as medical agents, to map processes directly into the company’s proprietary electronic health record system. We’re excited to partner with Adam and his team as they transform healthcare services into AI-powered software products, directly benefiting patients and doctors,” says Karel Zheng, Partner at KAYA VC.

“Jutro Medical has proven that primary care can be delivered differently—leveraging technology to provide high-quality medical care focused on patient value, all free of charge under Europe’s mandatory public health insurance. Adam and his team have built a vertically integrated healthcare provider covering the entire value chain. With their proprietary AI agents, they’re set to disrupt primary care across Europe, and I’m glad to support them on this journey,” says Piotr Siezieniewski, Partner at RIO ASI. 

Subscribe to our newsletter

Join our newsletter to get the best hottest startup tapas.

Popular posts

Swedish AI Startup Arkyv Raises €700K Pre-Seed to Bring Automation into Architecture Workflows

April 13, 2026

Eleven Labs CEO backs Warsaw’s Replenit’s $2.5M to become the reasoning layer of retail AI

April 13, 2026

Slovak startup TrollWall AI raises €800K from Seed Starter, Slovak Investment Holding and Miroslav Fedor to tackle online hate at scale

April 9, 2026

Related posts

The winner of the 10th edition of the Creative Business Czechia competition is the startup NABERIUS TECH, which develops अत्य realistic virtual environments for training artificial intelligence, robots, and simulations in real-world conditions. The Audience Award went to the project Knither. The national competition’s final evening confirmed the growing professionalism and importance of the Creative Tech sector.
by
Jakob Ulrych
The Munich-based startup Peak Quantum has secured €2.2 million in fresh capital, bringing its total funding to around €5 million. The capital increase is intended for the development of error-resilient quantum processors and the establishment of a European pilot manufacturing line. The focus is on scalable hardware and industrial applicability.
by
Jakob Ulrych
Kyiv-based AI startup Obriy AI has raised $500,000 from N1 Investment Company in a pre-seed round, alongside a long-term strategic partnership between the two sides, as Vestbee was informed.
by
Jakob Ulrych
Replenit, a Warsaw-based startup building an AI decision engine for retail that turns customer signals into real-time, individualised decisions, has raised €2.1 million ($2.5 million) in a pre-Seed funding round for product development, AI research, and operations and hiring.
by
Jakob Ulrych